TARGETED NANOVECTORS AND THEIR USE FOR TREATMENT OF BRAIN TUMORS

M Tour James (Inventor), Jacob Berlin (Inventor), Daniela Marcano (Inventor), S Baskin David (Inventor), A Sharpe Martyn (Inventor)

Research output: Patent

Abstract

In some embodiments, the invention pertains to therapeutic compositions for treating a brain tumor. Such therapeutic compositions generally comprise: (1) a nanovector; (2) an active agent associated with the nanovector with activity against brain tumor cells; and (3) a targeting agent associated with the nanovector with recognition activity for a marker of the brain tumor cells. In some embodiments, the active agent and the targeting agent are non-covalently associated with the nanovector. Additional embodiments of the present invention pertain to methods of treating a brain tumor in a subject (e.g., a human being) by administering the aforementioned therapeutic compositions to the subject. Further embodiments of the present disclosure pertain to methods of formulating therapeutic compositions for treating a brain tumor in a subject in a personalized manner.

Original languageEnglish (US)
Patent numberUS2014154269
IPCA61K 9/ 00 A I
Priority date4/26/12
StatePublished - Jun 5 2014
Externally publishedYes

Fingerprint Dive into the research topics of 'TARGETED NANOVECTORS AND THEIR USE FOR TREATMENT OF BRAIN TUMORS'. Together they form a unique fingerprint.

Cite this